Canadian Online Pharmacy

FDA offers new guidance on developing drugs for Alzheimer’s disease

You are subscribed to FDA Press Releases for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

02/07/2013 10:00 AM EST

Alzheimer's disease draft guidance

.


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery